Arumugam Balamurugan

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 335 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

Fabio Candotti, Kit L. Shaw, Linda Muul et al. · Blood · 2012 · 236 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Distinctive KIR and HLA diversity in a panel of north Indian Hindus

Raja Rajalingam, Peter Krausa, Heather Shilling et al. · Immunogenetics · 2002 · 155 citations

Social Sciences, Anthropology, Hindu Studies +4

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model

Saki Shimizu, Patrick Hong, Arumugam Balamurugan et al. · Blood · 2009 · 150 citations · Full text

Life Sciences, Immunology, Molecular Biology +9

Cytokine Polarization in Miliary and Pleural Tuberculosis

Surendra K. Sharma, Dipender Kumar Mitra, Arumugam Balamurugan et al. · Journal of Clinical Immunology · 2002 · 125 citations

Veterinary Medicine, Immunology, Infectious Diseases +14